Fourteen patients with Cushing's disease treated by trans-sphenoidal hypophysectomy between 1962 and 1975 were reviewed in 1983. Complete ablation had been attempted. There were no surgical deaths and one episode of bacterial meningitis. Two patients required a second operation for a cerebrospinal fluid leak. There have been three late deaths from unrelated causes. All patients had a biochemical remission of their Cushing's disease postoperatively and no relapse has been recorded. Most patients need some hormone replacement but residual pituitary function and sella radiography have remained stable. This treatment seems satisfactory and the evidence implies a pituitary aetiology of the syndrome.
Introduction
The rarity of Cushing's disease contributes to the continuing debate about its exact aetiology and best management; long-term follow up is of interest. Between 1962 and 1973, GAD catrried out trans-sphenoidal hypophysectomy on 12 women and one man aged 20 to 65 years with undoubted Cushing's disease. An earlier review (Carmalt et al. 1977 ) of these patients found no operative deaths, one episode of meningitis following a second operation to repair a cerebrospinal fluid leak and one death from myocarditis four years postoperatively; this last patient had not shown any evidence of relapse. Of the 12 surviving patients all, with one possible exception, were in remission, but 9 required hormone replacement. Of the 8 premenopausal women, it was remarkable that spontaneous menstruation returned in 5 and pregnancy occurred naturally in 3. Another patient has been followed up by us in recent years. This 20-year-old woman with florid Cushing's disease had a hypophysectomy iti 1962 at the Queen Elizabeth Hospital by Mr J Waldeck, using a transpalatal approach. Later, she developed a chronic cerebrospinal fluid leak and this defect was repaired by GAD in 1974. This is the only other patient so treated on whom we have long-term follow-up data so she has been included in this review, making 14 in all (Figure 1 ).
Method
The surgical technique employed in these patients was intended to remove all the pituitary gland rather than abnormal tissue only.
The patients were reviewed in 1983. Eight patients attended for clinical assessment, a blood sample and a lateral skull radiograph. In three instances information was kindly provided by other clinicians.
Results
Since the previous review 2 more patients have died. Of the 11 survivors, patient No. 4 was lost to follow up in 1981 but at that time was reported to be well without evidence of relapse and probably taking corticosteroids and thyroxine. Patient No. 7 is reported as being well without clinical evidence of relapse and taking medication only for menorrhagia. Patient No. 13 has no evidence of relapse and is often hypopituitary because of failure of compliance with replacement treatment.
All the 8 patients seen locally are considered to be in clinical remission because of the absence of the typical features of Cushing's syndrome which were well documented to be present prior to operation. The patients are generally well and euthyroid, although No. 11 appears older than her age of 41 years and is troubled by transient cardiac arrythmias of uncertain aetiology. Other conditions present include bronchial asthma, arthritis, cerebrovascular accident and hypertension. Of the 5 women who regained spontaneous menstruation after operation, Nos. 7, 8 and 12 still have regular menses but have had no further pregnancies. Patient No. 1 died before the 1976 review and No. 10 is post-menopausal at the age of 54 years. Assuming that the condition of patient No. 4 has not changed since 1981, of the 11 survivors, 8 patients need to take glucocorticoid replacement treatment and, of these, 5 need to take thyroxine also. Two women take oestrogen and 2 patients (Nos. 7 and 12) take no replacement treatment at all. No patient needs antidiuretic hormone.
Biochemistry
Serum cortisol levels were available on 9 patients and were all normal or low (the latter result in patients on variable replacement doses) confirming the absence of relapse of the Cushing's disease.
Serum thyroxine levels were normal in the patients not taking thyroxine replacement. A slightly raised level was noted in 2 patients on replacement. The serum level of follicle-stimulating hormone was measured in 7 patients. Very low levels were recorded except in the 3 patients with postoperative menstruation. A level of 24 u/l was noted in patient No. 10 who is now menopausal, and 45 u/l in No. 12 who is 47 years of age. Levels of thyrotrophin, growth hormone and prolactin were all low or normal in the 9 patients tested.
Radiological assessment in 8 patients has shown a normal pituitary fossa with no evidence of recurrence of any space-occupying lesion.
Discussion
Since Cushing's original description in 1932 there has been much debate regarding the pathophysiology of the disease. Excessive secretion of hypothalamic corticotrophin-releasing hormone would be capable, presumably, of inducing hyperplasia of the corticotrophs, but it remains in doubt if this would progress to a pituitary adenoma. Alternatively, a tumour secreting adrenal corticotrophic hormone could develop as a primary process in the adenohypophysis. The experience of our patients seems relevant. Although 6 of them have complete or partial retention of pituitary function, none has relapsed over a long period of time. The 5 women in whom spontaneous menstruation occurred postoperatively are of particular interest in this context, as presumably some vascular connection was established between the hypothalamus and the residual or regenerated pituitary tissue. All this implies a primary pituitary aetiology.
Just as the aetiology remains controversial, so the recommended management is diverse. It is now widely accepted that treatment should be directed at the pituitary by surgery, interstitial irradiation or external radiotherapy, although an adrenal approach has its advocates.
Surgery in these 14 patients was intended to secure a complete clearance of the pituitary fossa using the standard transethmoidosphenoidal approach as described by Riskaer et al. (1961) , James (1964) and Kapur & Dalton (1969) , although evidently this was not always achieved. Many surgeons now advocate pituitary adenomectomy only in the hope of preserving pituitary function. Unfortunately, this procedure is not always curative. For example, in a recently reported series using selective microadenomectomy (Bigos et al. 1980 ), 6 patients out of 24 were not cured and 2 more relapsed. Boggan et al. (1983) reported 88 patients treated exclusively by microadenomectomy, of which 14 were not cured and 4 more relapsed. By contrast, in this present series all the patients were cured (except one with partial remission) and none relapsed. Similarly, Thomas & Richards (1983) used radical hypophysectomy in 14 patients and all were cured (except one with partial remission). The price is that most of these patients need to take some replacement treatment. It seems to be the case that whatever level of pituitary function is established postoperatively, this persists for a long time without improvement or deterioration. Our evidence indicates that attempted complete pituitary ablation is almost always curative for Cushing's disease without late relapse or complications, and we submit that this technique is the best present compromise.
